RRML - Risk factors for Mycobacterium tuberculosis resistance and detection of resistance mutations to Rifampin and Isoniazid by Real-Time PCR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Română English

Journal Metrics

Impact Factor 0.493
Five Year Impact Factor 0.531
SNIP 0.373
JCI 0.17

Advanced search

Top 10 downloaded articles
- August 2022 -
Downregulation of hsa-miR-4328... 8
Romanian Review of Laboratory ... 7
Antibacterial Activity of Clov... 7
The Effect of Resveratrol on S... 6
Carbapenem resistance determin... 6
Writing a Scientific Paper in ... 5
COVID-19 associated coagulopat... 5
Non-inhibitory effects of the ... 5
SPP1 is a biomarker of cervica... 5
Elbow Septic Arthritis caused ... 5

Log in

Concept, Design & Programming
Dr. Adrian Man

Nr. 18(2)/2010

Risk factors for Mycobacterium tuberculosis resistance and detection of resistance mutations to Rifampin and Isoniazid by Real-Time PCR

Adriana Hristea, Dan Otelea, Anca Macri, Cristian Baicus, Olga Moldovan, Mihaela Tinischi, Simona Paraschiv, Ruxandra Moroti, Victoria Arama, Adrian Streinu-Cercel


Objectives The objectives of our study were 1) to define risk factors for antimicrobial-resistant Mycobacterium tuberculosis (MTB) 2) to evaluate the use of real-time PCR-based technique for the prediction of phenotypic resistance of MTB. Methods We performed a prospective study in which we considered all 120 patients with smear-positive tuberculosis who were admitted to two clinical wards of the Marius Nasta Institute of Pneumology within a period of one year. Only data from 103 patients who underwent bacteriological investigations, including sensitivity tests, and who had filled out a questionnaire was analyzed. Fourteen patients with culture-confirmed tuberculosis resistant to any first line drug were compared to patients with fully susceptible disease. Sixty-seven MTB strains (26 drug-resistant and 41 drug-susceptible) were tested using a method recommended for the Light Cycler platform. For rifampin resistance, two regions of rpoB gene were targeted, while for identification of isoniazid resistance, we searched for mutations in katG and inhA genes. The susceptibility testing was performed using the absolute concentration method. Results We noted that while MTB resistance tends to be lower in new cases (3.7%), in patients with retreatment this resistance is much higher (44%), especially multidrug resistance (MDR), which accounts for 36% of cases of retreatment vs. 1.2% of new cases. Drug resistance was significantly associated only with previous antituberculous treatment (OR 19.56, CI 95% (3.96-94.41, p<0.005).The sensitivity and specificity of the rapid detection of mutations for isoniazid were 96% (95% CI: 88-100), respectively 95% (95% CI: 89-100), while for the rifampin resistance, sensitivity and specificity were 92% (95% CI: 81-100%), and 74% (95% CI: 61-87%) respectively. In our isolates the main resistance mechanism to isoniazid was related to changes in the katG gene that encodes catalase. Using this method, the best accuracy for genotyping compared to phenotypic resistance testing was obtained in what concerned detecting isoniazid resistance mutations. We found that for rifampin resistance the correlation between the predicted and observed phenotype was less than satisfactory. Conclusion MTB resistance was significantly associated only with previous antituberculous treatment. Real-time PCR assays represent a valuable diagnostic tool but they are not yet completely satisfactory for the detection of drug-resistant MTB.

Keywords: Mycobacterium tuberculosis,risk factors,resistance,Real-Time PCR

  PDF Download full text PDF
(1159 KB)
  Retraction Retraction of article